Overactive Bladder: Patient-Centric Management
Free For AAFP Members
More than 33 million people currently cope with physical issues related to overactive bladder (OAB). Unfortunately, many believe OAB is a normal effect of aging and are embarrassed to discuss the topic with their physician. Learn the latest evidence-based recommendations and guidelines to better assess and care for your patients who struggle with OAB.
Participate in this dynamic learning activity, which includes:
- Physician-patient video vignettes
- Split-screen video and slide presentations
- And interactive games
Earn 1.5 AAFP Prescribed credits. This activity is free for AAFP members.
Enhance your patient care today and earn up to 2 additional AAFP Prescribed credits when you complete the Translation to Practice® (t2p™) process.
About this CME Activity
After completing this CME activity, you should be able to:
- Understand the primary causes of poor outcomes in patients with overactive bladder and evaluate practical ways of overcoming these issues.
- Engage with patients to determine if they have symptoms of overactive bladder, and if so educate them on appropriate behavioral modifications to control the condition.
- Create an action plan for incorporating therapeutics into patient management for overactive bladder that balances the need for effective control of symptoms with adverse effects and patient preferences.
To be eligible to report CME credit, please complete the full module in one sitting.
Estimated time required to complete the full module: 1 hour 30 minutes
Original release date: July 29, 2016
Margot Savoy, MD, MPH, FAAFP, FABC, CPE
Medical Director & Residency Faculty, Department of Family & Community Medicine, Christiana Care Health System; Clinical Assistant Professor, Sidney Kimmel College of Medicine at Thomas Jefferson University, Wilmington, Delaware
Michael Sevilla, MD
Assistant Professor in Family and Community Medicine, Northeast Ohio Medical University; Private Practice, Family Practice Center of Salem, Salem, Ohio
This enduring material activity, Overactive Bladder: Patient-Centric Management, has been reviewed and is acceptable for up to 1.50 Prescribed credits by the American Academy of Family Physicians. Term of approval begins July 29, 2016. Term of approval is for 2 years from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AAFP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Family Physicians designates this Enduring Material activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Following this CME activity, participants have the opportunity to earn additional credits by participating in a Translation to Practice® exercise. Information on Translation to Practice® (t2p™) will be shared within the activity.
CME activities approved for AAFP credit are recognized by the AOA as equivalent to AOA Category 2 credit.
The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. Please note that medical information is constantly changing; the information contained in this activity was accurate at the time of publication. This material is not intended to represent the only, nor necessarily best, methods or procedures appropriate for the medical situations discussed. Rather, it is intended to present an approach, view, statement, or opinion of the faculty, which may be helpful to others who face similar situations.
The AAFP disclaims any and all liability for injury or other damages resulting to any individual using this material and for all claims that might arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by a physician or any other person. Physicians may care to check specific details such as drug doses and contraindications, etc., in standard sources prior to clinical application. This material might contain recommendations/guidelines developed by other organizations. Please note that although these guidelines might be included, this does not necessarily imply the endorsement by the AAFP.
The faculty for this activity have made all reasonable efforts to ensure the information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation. Information regarding drugs (eg, administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and delivery systems is subject to change.
The reader is advised to check the manufacturer’s insert and medical references for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering any drug.